Myelodysplastic Syndromes

Showing NaN - NaN of 35

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Magrolimab
  • +2 more
  • Birmingham, Alabama
  • +168 more
Dec 7, 2022

Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML, Other IDH1-mutated Positive Hematologic Malignancies Trial

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • +3 more
  • Birmingham, Alabama
  • +26 more
Sep 12, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Acute Leukemia, MDS Trial in Atlanta (Interferon gamma (IFN?)-primed human bone marrow-derived mesenchymal stromal cells)

Recruiting
  • Acute Leukemia
  • Myelodysplastic Syndromes
  • Interferon gamma (IFNγ)-primed human bone marrow-derived mesenchymal stromal cells
  • Atlanta, Georgia
  • +2 more
Jul 15, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • BPX-501 dose 1
  • +5 more
  • Atlanta, Georgia
  • +7 more
Jul 10, 2022

Acute Myeloid Leukemia, MDS, Glioblastoma Multiforme Trial in United States (DSP-7888 Dosing Emulsion)

Completed
  • Acute Myeloid Leukemia
  • +8 more
  • DSP-7888 Dosing Emulsion
  • Denver, Colorado
  • +7 more
Apr 4, 2022

MDS Trial in Worldwide (Luspatercept, Placebo)

Completed
  • Myelodysplastic Syndromes
  • Stanford, California
  • +73 more
Nov 19, 2021

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in United States (TregGraft (Orca-T))

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • TregGraft (Orca-T)
  • Duarte, California
  • +13 more
Oct 28, 2021

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in United States (OrcaGraft (Orca-Q))

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • OrcaGraft (Orca-Q)
  • Duarte, California
  • +7 more
Oct 28, 2021

Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Canada, United States (CPX-351)

Completed
  • Hematologic Malignancy
  • +4 more
  • Washington, District of Columbia
  • +12 more
Jul 20, 2021

Connect® Myeloid Disease Registry

Recruiting
  • Primary Myelofibrosis
  • +2 more
    • Huntsville, Alabama
    • +228 more
    Mar 30, 2021

    MDS Trial in Canada, United States (anti-thymocyte globulin)

    Completed
    • Myelodysplastic Syndromes
    • anti-thymocyte globulin
    • Washington, District of Columbia
    • +27 more
    Jan 24, 2021

    Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumors Trial in United States (arsenic trioxide)

    Terminated
    • Leukemia
    • +2 more
    • arsenic trioxide
    • Tucson, Arizona
    • +7 more
    Oct 2, 2020

    MDS Trial in United States (ARRY-614, p38/Tie2 inhibitor; oral)

    Completed
    • Myelodysplastic Syndromes
    • ARRY-614, p38/Tie2 inhibitor; oral
    • Tampa, Florida
    • +3 more
    Sep 4, 2020

    MDS Trial in Tampa, Atlanta, Houston (ARRY-614, p38/Tie2 inhibitor; oral)

    Completed
    • Myelodysplastic Syndromes
    • ARRY-614, p38/Tie2 inhibitor; oral
    • Tampa, Florida
    • +2 more
    Sep 4, 2020

    MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)

    Completed
    • Myelodysplastic Syndromes
    • +3 more
    • ON 01910.Na
    • Scottsdale, Arizona
    • +86 more
    Jun 29, 2020

    Leukemia, MDS Trial in Atlanta, Baltimore (bevacizumab, cytarabine, mitoxantrone HCl)

    Completed
    • Leukemia
    • Myelodysplastic Syndromes
    • bevacizumab
    • +2 more
    • Atlanta, Georgia
    • +2 more
    Oct 15, 2019

    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

    Completed
    • Leukemia
    • +4 more
    • therapeutic allogeneic lymphocytes
    • +6 more
    • Denver, Colorado
    • +13 more
    Sep 13, 2019

    Leukemia, MDS Trial in United States (biological, drug, procedure, radiation)

    Terminated
    • Leukemia
    • Myelodysplastic Syndromes
    • anti-thymocyte globulin
    • +4 more
    • Tampa, Florida
    • +8 more
    Dec 3, 2017

    Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Chronic Trial in France, United States

    Completed
    • Leukemia, Myelocytic, Acute
    • +3 more
    • Duarte, California
    • +23 more
    Feb 8, 2016

    Bone Marrow and Blood Samples From Leukemia or Other

    Completed
    • Leukemia
    • +2 more
    • cytogenetic analysis
    • fluorescence in situ hybridization
    • Mobile, Alabama
    • +279 more
    Mar 5, 2015

    S9910, Collecting and Storing Blood and Bone Marrow Samples From

    Completed
    • Leukemia
    • +2 more
    • biologic sample preservation procedure
    • Ft. Smith, Arkansas
    • +291 more
    Mar 5, 2015

    Leukemia, MDS Trial in United States (anti-thymocyte globulin, cyclosporine)

    Completed
    • Leukemia
    • Myelodysplastic Syndromes
    • Mobile, Alabama
    • +93 more
    Mar 5, 2015

    Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in United States (ruxolitinib phosphate, laboratory biomarker

    Completed
    • Chronic Myeloproliferative Disorders
    • +4 more
    • ruxolitinib phosphate
    • +2 more
    • Birmingham, Alabama
    • +23 more
    Oct 22, 2014